Biohaven's Clinical Data On BHV-1530, A Novel FGFR3-Directed ADC With A Proprietary Topoisomerase I (Topoix) Payload, Selected For Oral Presentation At The EORTC-NCI-AACR Symposium 2026

(MENAFN - PR Newswire) Oral presentation selected: Phase 1 findings from the ongoing BHV1530-101 study will be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium on Molecular ...